1. Home
  2. LYG vs SNY Comparison

LYG vs SNY Comparison

Compare LYG & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lloyds Banking Group Plc

LYG

Lloyds Banking Group Plc

HOLD

Current Price

$6.21

Market Cap

90.5B

Sector

Finance

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$43.61

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYG
SNY
Founded
1695
1994
Country
United Kingdom
France
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.5B
104.5B
IPO Year
2012
2001

Fundamental Metrics

Financial Performance
Metric
LYG
SNY
Price
$6.21
$43.61
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
N/A
$58.00
AVG Volume (30 Days)
15.1M
3.3M
Earning Date
04-29-2026
04-23-2026
Dividend Yield
3.73%
3.47%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.36
$3.49
Revenue Next Year
$7.28
$6.10
P/E Ratio
$62.13
$6.14
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$40.89
52 Week High
$6.34
$52.68

Technical Indicators

Market Signals
Indicator
LYG
SNY
Relative Strength Index (RSI) 56.56 50.80
Support Level $5.84 $43.32
Resistance Level $6.33 $45.22
Average True Range (ATR) 0.09 0.66
MACD -0.01 0.02
Stochastic Oscillator 77.66 50.88

Price Performance

Historical Comparison
LYG
SNY

About LYG Lloyds Banking Group Plc

Lloyds is a retail and commercial bank headquartered in the United Kingdom. The bank operates via three business segments: retail, commercial banking, and insurance and wealth. In retail, Lloyds offers primarily mortgages (66% of its loan portfolio), credit cards, and current accounts to its customers. Its commercial banking operation provides lending, transaction banking, working capital management, and debt capital market services to large companies and financial institutions in the UK. Insurance and wealth round out the product lineup with life and property insurance as well as pension solutions and high-net-worth asset management services.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: